Clinical Trial Update: Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating adult human mesenchymal stem cells for efficacy and safety in steroid-refractory acute graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Mesoblast Mesenchymal Stem Cells (adult human) (mesenchymal stem cells)

Snippet

Sponsor: Mesoblast, Inc. | Conditions: Graft Versus Host Disease | Phase 3 | Status: COMPLETED